FindTrial
Sign In

Estimating pathological importance for comparison between core needle biopsy and general pathology: targeting breast tissues

Estimating pathological importance for comparison between core needle biopsy and general pathology: targeting breast tissues

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026843
Enrollment
Unknown
Registered
2019-10-24
Start date
2006-01-01
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

neoadjuvant:Nil
non-neoadjuvan:Nil

Sponsors

Department of Pathology, Tongzhou Maternal and Child Health Hospital of Beijing
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
29 Years to 73 Years

Inclusion criteria

Inclusion criteria: patients with primary breast cancer

Exclusion criteria

Exclusion criteria: patients had other cancers, and/or during in the perinatal period

Design outcomes

Primary

MeasureTime frame
pathological tissues;—

Countries

China

Contacts

Public ContactChunjie Sun

Department of Pathology, Tongzhou Maternal and Child Health Hospital of Beijing

puhjfebt@163.com+86 14763482294

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026